NASDAQ:BMRA Biomerica (BMRA) Stock Price, News & Analysis → Global crypto currency reset (41 major banks signed up) (From Stansberry Research) (Ad) Free BMRA Stock Alerts $0.72 0.00 (-0.37%) (As of 05:11 PM ET) Add Compare Share Share Today's Range$0.72▼$0.7850-Day Range$0.72▼$1.2952-Week Range$0.70▼$2.13Volume48,550 shsAverage Volume82,267 shsMarket Capitalization$12.14 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Get Biomerica alerts: Email Address Ad Stansberry ResearchGlobal crypto currency reset (41 major banks signed up)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project... Here's everything you need to know. About Biomerica Stock (NASDAQ:BMRA)Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations. It primarily sells its products for gastrointestinal diseases, food intolerances, and various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also developing InFoods IBS, that uses a simple blood sample to identify patient-specific foods which may alleviate irritable bowel syndrome symptoms; and H. Pylori diagnostic test that indicates if a patient is infected with the H. Pylori bacteria. In addition, it develops products to indicate if a person has been infected by COVID-19. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California.Read More BMRA Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BMRA Stock News HeadlinesApril 23, 2024 | americanbankingnews.comBiomerica (NASDAQ:BMRA) Share Price Crosses Below 200-Day Moving Average of $0.97April 16, 2024 | investing.comBiomerica expands offices, secures new patentsApril 23, 2024 | Stansberry Research (Ad)Global crypto currency reset (41 major banks signed up)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project...April 15, 2024 | globenewswire.comBiomerica provides update on inFoods® IBS expansionApril 15, 2024 | americanbankingnews.comBiomerica (NASDAQ:BMRA) Posts Quarterly Earnings ResultsApril 15, 2024 | msn.comBiomerica GAAP EPS of -$0.11, revenue of $1MApril 13, 2024 | investorplace.comBMRA Stock Earnings: Biomerica Reported Results for Q3 2024April 12, 2024 | globenewswire.comBiomerica Reports Third Quarter 2024 Financial ResultsApril 23, 2024 | Stansberry Research (Ad)Global crypto currency reset (41 major banks signed up)Behind closed doors, at least 41 major US banks have signed up to a strange new crypto project...March 28, 2024 | globenewswire.comBiomerica InFoods IBS Data to be Presented at the Upcoming Digestive Disease Week (DDW) 2024 ConferenceMarch 10, 2024 | morningstar.comBiomerica Inc BMRAFebruary 23, 2024 | benzinga.comBiomerica Stock (NASDAQ:BMRA), Short Interest ReportFebruary 21, 2024 | finance.yahoo.comDiagnostics Industry Leader Gary Huff Appointed to Biomerica Strategic Advisory BoardFebruary 21, 2024 | globenewswire.comDiagnostics Industry Leader Gary Huff Appointed to Biomerica Strategic Advisory BoardFebruary 20, 2024 | barrons.comBiomerica Inc.February 17, 2024 | finance.yahoo.comBMRA Mar 2024 2.500 callFebruary 5, 2024 | benzinga.comBiomerica Stock (NASDAQ:BMRA) Dividends: History, Yield and DatesJanuary 23, 2024 | finance.yahoo.comDiagnostics Industry Leader Jack Kenny Appointed as Chairman of the Board at BiomericaJanuary 16, 2024 | markets.businessinsider.comBiomerica Reports Second Quarter 2024 Financial ResultsDecember 20, 2023 | finance.yahoo.comIs Biomerica (NASDAQ:BMRA) In A Good Position To Deliver On Growth Plans?December 19, 2023 | msn.comBiomerica swings 501(k) clearance for H. pylori bacteria diagnostic testDecember 18, 2023 | markets.businessinsider.comNasdaq Gains 100 Points; Biomerica Shares Spike HigherDecember 18, 2023 | msn.comWhy Is Diagnostics Products Focused Biomerica Stock Trading Higher Today?December 18, 2023 | finance.yahoo.comBiomerica Received US FDA 510(k) Clearance for Their Hp Detect™ ELISA Test Product Designed to Detect the Presence of the H. pylori Bacteria That infects Approximately 35% of the U.S. PopulationNovember 10, 2023 | tmcnet.comBiomerica to Participate in 14th Annual Craig-Hallum Alpha Select Conference on November 16November 8, 2023 | finance.yahoo.comBiomerica Expands inFoods IBS Reach with Addition of Several New GI GroupsOctober 13, 2023 | markets.businessinsider.comREPEAT - Biomerica Reports First Quarter 2024 Financial ResultsSee More Headlines Receive BMRA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Biomerica and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings4/12/2024Today4/23/2024Fiscal Year End5/31/2024Next Earnings (Estimated)8/23/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Diagnostic substances Sub-IndustryN/A Current SymbolNASDAQ:BMRA CUSIPN/A CIK73290 Webwww.biomerica.com Phone(949) 645-2111Fax949-553-1231Employees62Year Founded1971Profitability EPS (Most Recent Fiscal Year)($0.37) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-7,140,000.00 Net Margins-117.46% Pretax Margin-116.58% Return on Equity-64.00% Return on Assets-50.95% Debt Debt-to-Equity RatioN/A Current Ratio4.44 Quick Ratio3.37 Sales & Book Value Annual Sales$5.34 million Price / Sales2.30 Cash FlowN/A Price / Cash FlowN/A Book Value$0.70 per share Price / Book1.04Miscellaneous Outstanding Shares16,820,000Free Float14,551,000Market Cap$12.30 million OptionableOptionable Beta-1.04 Social Links The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report Key ExecutivesMr. Zackary S. Irani (Age 58)Chief Executive Officer Comp: $141.25kMr. Allen C. Barbieri (Age 66)Executive Vice-Chairman of the Board & Corporate Secretary Comp: $126.25kMr. Gary Lu CPA (Age 43)Principal Accounting Officer & CFO Comp: $260kMs. Lucy Liu Ph.D.Director of Manufacturing & Technical OperationsMr. Robert W. CarlsonChief Commercial OfficerKey CompetitorsTrinity BiotechNASDAQ:TRIBMyMD PharmaceuticalsNASDAQ:MYMDNavidea BiopharmaceuticalsNYSE:NAVBCardio DiagnosticsNASDAQ:CDIOOncoCyteNASDAQ:OCXView All CompetitorsInsiders & InstitutionsHeritage Investors Management CorpSold 35,750 shares on 2/7/2024Ownership: 0.206%Russell Investments Group Ltd.Bought 26,288 shares on 2/5/2024Ownership: 1.198%Zackary S IraniBought 500 shares on 5/24/2023Total: $805.00 ($1.61/share)Zackary S IraniBought 1,700 shares on 5/12/2023Total: $1,989.00 ($1.17/share)Zackary S IraniBought 300 shares on 5/9/2023Total: $417.00 ($1.39/share)View All Insider TransactionsView All Institutional Transactions BMRA Stock Analysis - Frequently Asked Questions How have BMRA shares performed in 2024? Biomerica's stock was trading at $1.25 on January 1st, 2024. Since then, BMRA shares have decreased by 42.3% and is now trading at $0.7215. View the best growth stocks for 2024 here. Are investors shorting Biomerica? Biomerica saw a drop in short interest in the month of March. As of March 31st, there was short interest totaling 66,500 shares, a drop of 13.3% from the March 15th total of 76,700 shares. Based on an average daily volume of 59,100 shares, the short-interest ratio is presently 1.1 days. View Biomerica's Short Interest. When is Biomerica's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Friday, August 23rd 2024. View our BMRA earnings forecast. How were Biomerica's earnings last quarter? Biomerica, Inc. (NASDAQ:BMRA) posted its quarterly earnings data on Friday, April, 12th. The company reported ($0.11) earnings per share (EPS) for the quarter. The company had revenue of $1.02 million for the quarter. Biomerica had a negative trailing twelve-month return on equity of 64.00% and a negative net margin of 117.46%. What other stocks do shareholders of Biomerica own? Based on aggregate information from My MarketBeat watchlists, some companies that other Biomerica investors own include Sorrento Therapeutics (SRNE), Pfizer (PFE), Johnson & Johnson (JNJ), OPKO Health (OPK), TG Therapeutics (TGTX), Advanced Micro Devices (AMD), Co-Diagnostics (CODX), FuelCell Energy (FCEL) and Trevena (TRVN). How do I buy shares of Biomerica? Shares of BMRA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:BMRA) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersSHOCKING Crypto Leak…Crypto 101 Mediatop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingHow to camouflage a factory of 53,000 workersStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”AltimetryExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersExposed: How Big Banks Plan to Chain Your Wealth with Digital DollarsGoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biomerica, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
